Calcium Gluconate Treatment for Hyperkalemia

Introduction to Hyperkalemia Management

The American College of Cardiology recommends administering 10% calcium gluconate at 15-30 mL IV over 2-5 minutes for cardiac membrane stabilization in adults with hyperkalemia 1
For pediatric patients with hyperkalemia, the recommended dose of calcium gluconate is 100-200 mg/kg/dose via slow infusion with ECG monitoring 2

Calcium gluconate is preferred over calcium chloride when administering through a peripheral IV line, as calcium chloride can cause severe tissue injury if extravasation occurs 1
Calcium administration does not lower serum potassium but protects against cardiac arrhythmias by stabilizing cardiac membranes 1
The effects of calcium administration begin within 1-3 minutes but are temporary, lasting only 30-60 minutes 3, 1

Monitor heart rate during calcium administration and stop injection if symptomatic bradycardia occurs 1
Calcium should not be administered through the same line as sodium bicarbonate to avoid precipitation 2
In patients with high phosphate levels, increased calcium might increase the risk of calcium phosphate precipitation in tissues 2

Administer 10% calcium gluconate: 15-30 mL IV over 2-5 minutes for cardiac membrane stabilization 1
Insulin with glucose: 10 units regular insulin IV with 25g glucose (50 mL of D50W) over 15-30 minutes 1
Sodium bicarbonate: 50 mEq IV over 5 minutes (most effective in patients with concurrent metabolic acidosis) 1

For patients with renal failure, hemodialysis is the most effective method for severe hyperkalemia 1
For patients with concurrent metabolic acidosis, sodium bicarbonate may be more effective as part of the treatment regimen 3, 1
Monitor serum potassium levels closely during treatment to avoid overcorrection and hypokalemia 1

If no effect is observed within 5 to 10 minutes after the initial dose of calcium gluconate, a second dose may be given, as recommended by the Mayo Clinic Proceedings 4, 5
The onset of action is rapid, occurring within 1-3 minutes of administration, according to the Mayo Clinic Proceedings 4, 5

Monitor the ECG response for 5-10 minutes after the initial dose, as suggested by the Mayo Clinic Proceedings 4, 5
A second dose of calcium gluconate may be administered if no clinical or ECG improvement is observed within this timeframe, as recommended by the Mayo Clinic Proceedings 4, 5

Calcium administration is a temporizing measure only—concurrent therapies to shift potassium intracellularly and promote elimination must be initiated simultaneously, according to the Mayo Clinic Proceedings 4, 5

The Mayo Clinic recommends administering calcium gluconate for hyperkalemia with ECG changes, with the effect occurring within 1-3 minutes of administration, and if no ECG improvement is observed within 5-10 minutes, a second dose may be administered 6
The American Heart Association implies that concurrent therapies, such as promoting potassium elimination with furosemide 40-80 mg IV or hemodialysis for severe cases, must be initiated simultaneously with calcium gluconate administration 6

The Mayo Clinic suggests that calcium gluconate may be used for cardiac membrane stabilization, but concurrent therapies such as insulin and glucose to shift potassium intracellularly, and furosemide or hemodialysis to promote potassium elimination, must be initiated simultaneously 6